U-AZN

Q:AZN - ASTRAZENECA PLC SPON ADR EACH REP 0.50 ORD SHS - http://www.astrazeneca.com

18:22:24 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
AZN - Q	5.0	69.66	·	70.83	0.1	70.85	+0.72	1.0	5,803.7	406,986	37,895	70.40 71.10 70.16	76.56 60.47	18:01:22	Apr 16	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Up -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 37895

Date ET	Symbol	Type	Headline
2024-04-16 07:00	U:AZN	News Release200	IMFINZI(TM) (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
2024-04-11 07:00	U:AZN	News Release200	FASENRA approved for treatment of children aged 6 to 11 with severe asthma
2024-04-05 23:10	U:AZN	News Release200	ENHERTU(TM) Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
2024-04-05 21:43	U:AZN	News Release200	ENHERTU(TM) (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumors
2024-04-05 07:00	U:AZN	News Release200	IMFINZI(TM) (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial
2024-04-02 07:00	U:AZN	News Release200	Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer
2024-04-01 07:00	U:AZN	News Release200	VOYDEYA(TM) approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH

Date ET

Symbol

Type

Headline

2024-04-16 07:00

News Release

2024-04-11 07:00

News Release